Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myelin basic protein (MBP) mRNA is localized to the myelin membranes of oligodendrocytes. When exogenous
MBP mRNA
is microinjected into oligodendrocytes in culture, it is transported along the processes and localized to the myelin compartment in a multistep intracellular RNA trafficking pathway. In the work described here, oligodendrocytes were treated with agents that affect the cytoskeleton including: nocodazole, to disrupt microtubules; taxol, to stabilize microtubules; cytochalasin, to disrupt microfilaments; and
kinesin
anti-sense oligonucleotide, to suppress
kinesin
expression. Digoxigenin-labeled
MBP mRNA
was microinjected into the treated cells and the extent of translocation of the microinjected RNA was determined by confocal microscopy. Nocodazole, taxol, and
kinesin
anti-sense oligonucleotide inhibited translocation of microinjected
MBP mRNA
, while cytochalasin B and
kinesin
sense oligonucleotide did not. These results indicate that translocation of
MBP mRNA
in oligodendrocytes requires intact microtubules and
kinesin
but does not require intact microfilaments. The results are discussed in relation to the current multistep model for intracellular RNA trafficking in oligodendrocytes.
...
PMID:Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubules and kinesin. 941 74
The results presented here identify a new RNA trafficking phenotype in taiep oligodendrocytes that increases the frequency of reversals and restricts the extent of transport of RNA containing the A2RE transport signal from
MBP mRNA
. The taiep rat is a myelin mutant characterized by excessive accumulation of microtubules in oligodendrocytes and myelin deficiency in the central nervous system. The taiep RNA trafficking is developmentally correlated with the microtubule accumulation in oligodendrocytes and can be partially suppressed by reducing microtubule density with nocodazole or inhibiting dynein activity by coinjecting anti-dynein antibodies. These results suggest that RNA trafficking in taiep oligodendrocytes is inhibited by enhanced dynein activity that neutralizes or lessens the normal overriding power of the plus-end directed motor
kinesin
. Altered orientation of microtubules in oligodendrocyte fine processes and a physical barrier created by densely packed microtubules may also contribute to the inhibition of RNA trafficking in taiep oligodendrocytes.
...
PMID:RNA transport in oligodendrocytes from the taiep mutant rat. 1469 59
Oligodendrocytes in the central nervous system produce myelin, a lipid-rich, multilamellar sheath that surrounds axons and promotes the rapid propagation of action potentials. A critical component of myelin is myelin basic protein (MBP), expression of which requires anterograde mRNA transport followed by local translation at the developing myelin sheath. Although the anterograde motor
kinesin
KIF1B is involved in
mbp
mRNA transport in zebrafish, it is not entirely clear how
mbp
transport is regulated. From a forward genetic screen for myelination defects in zebrafish, we identified a mutation in
actr10
, which encodes the Arp11 subunit of dynactin, a critical activator of the retrograde motor dynein. Both the
actr10
mutation and pharmacological dynein inhibition in zebrafish result in failure to properly distribute
mbp
mRNA in oligodendrocytes, indicating a paradoxical role for the retrograde dynein/dynactin complex in anterograde
mbp
mRNA transport. To address the molecular mechanism underlying this observation, we biochemically isolated reporter-tagged
Mbp
mRNA granules from primary cultured mammalian oligodendrocytes to show that they indeed associate with the retrograde motor complex. Next, we used live-cell imaging to show that acute pharmacological dynein inhibition quickly arrests
Mbp
mRNA transport in both directions. Chronic pharmacological dynein inhibition also abrogates
Mbp
mRNA distribution and dramatically decreases
MBP protein
levels. Thus, these cell culture and whole animal studies demonstrate a role for the retrograde dynein/dynactin motor complex in anterograde
mbp
mRNA transport and myelination in vivo.
...
PMID:Dynein/dynactin is necessary for anterograde transport of
Mbp
mRNA in oligodendrocytes and for myelination in vivo. 2907 12
Giardia lamblia is a binucleate protistan parasite causing significant diarrheal disease worldwide. An inability to target Cas9 to both nuclei, combined with the lack of nonhomologous end joining and markers for positive selection, has stalled the adaptation of CRISPR/Cas9-mediated genetic tools for this widespread parasite. CRISPR interference (CRISPRi) is a modification of the CRISPR/Cas9 system that directs catalytically inactive Cas9 (dCas9) to target loci for stable transcriptional repression. Using a Giardia nuclear localization signal to target dCas9 to both nuclei, we developed efficient and stable CRISPRi-mediated transcriptional repression of exogenous and endogenous genes in Giardia. Specifically, CRISPRi knockdown of
kinesin
-2a and
kinesin
-13 causes severe flagellar length defects that mirror defects with morpholino knockdown. Knockdown of the ventral disk
MBP protein
also causes severe structural defects that are highly prevalent and persist in the population more than 5 d longer than defects associated with transient morpholino-based knockdown. By expressing two guide RNAs in tandem to simultaneously knock down
kinesin
-13 and MBP, we created a stable dual knockdown strain with both flagellar length and disk defects. The efficiency and simplicity of CRISPRi in polyploid Giardia allows rapid evaluation of knockdown phenotypes and highlights the utility of CRISPRi for emerging model systems.
...
PMID:Robust and stable transcriptional repression in Giardia using CRISPRi. 3037 14